1. Home
  2. SRPT vs MTZ Comparison

SRPT vs MTZ Comparison

Compare SRPT & MTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • MTZ
  • Stock Information
  • Founded
  • SRPT 1980
  • MTZ 1929
  • Country
  • SRPT United States
  • MTZ United States
  • Employees
  • SRPT N/A
  • MTZ N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • MTZ Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • SRPT Health Care
  • MTZ Industrials
  • Exchange
  • SRPT Nasdaq
  • MTZ Nasdaq
  • Market Cap
  • SRPT 12.2B
  • MTZ 10.7B
  • IPO Year
  • SRPT 1997
  • MTZ N/A
  • Fundamental
  • Price
  • SRPT $104.54
  • MTZ $135.93
  • Analyst Decision
  • SRPT Strong Buy
  • MTZ Strong Buy
  • Analyst Count
  • SRPT 21
  • MTZ 14
  • Target Price
  • SRPT $182.00
  • MTZ $146.57
  • AVG Volume (30 Days)
  • SRPT 1.0M
  • MTZ 925.2K
  • Earning Date
  • SRPT 11-06-2024
  • MTZ 10-31-2024
  • Dividend Yield
  • SRPT N/A
  • MTZ N/A
  • EPS Growth
  • SRPT N/A
  • MTZ N/A
  • EPS
  • SRPT 1.22
  • MTZ 1.13
  • Revenue
  • SRPT $1,640,348,000.00
  • MTZ $12,180,445,000.00
  • Revenue This Year
  • SRPT $45.98
  • MTZ $2.92
  • Revenue Next Year
  • SRPT $78.13
  • MTZ $8.94
  • P/E Ratio
  • SRPT $85.70
  • MTZ $119.96
  • Revenue Growth
  • SRPT 48.45
  • MTZ 3.89
  • 52 Week Low
  • SRPT $78.67
  • MTZ $52.88
  • 52 Week High
  • SRPT $173.25
  • MTZ $147.23
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 23.65
  • MTZ 57.87
  • Support Level
  • SRPT $116.32
  • MTZ $137.52
  • Resistance Level
  • SRPT $122.63
  • MTZ $147.23
  • Average True Range (ATR)
  • SRPT 4.97
  • MTZ 4.77
  • MACD
  • SRPT -2.19
  • MTZ 0.24
  • Stochastic Oscillator
  • SRPT 6.47
  • MTZ 61.03

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.

About MTZ MasTec Inc.

MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. The company's primary activities include the engineering, building, installation, maintenance, and upgrade of communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five reportable segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.

Share on Social Networks: